These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34078530)

  • 1. Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca
    Koo BH; Lee J; Jin Y; Lim HK; Ryoo S
    BMB Rep; 2021 Oct; 54(10):516-521. PubMed ID: 34078530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p32-Dependent p38 MAPK Activation by Arginase II Downregulation Contributes to Endothelial Nitric Oxide Synthase Activation in HUVECs.
    Koo BH; Won MH; Kim YM; Ryoo S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32046324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginase II Contributes to the Ca
    Koo BH; Hwang HM; Yi BG; Lim HK; Jeon BH; Hoe KL; Kwon YG; Won MH; Kim YM; Berkowitz DE; Ryoo S
    J Am Heart Assoc; 2018 Sep; 7(18):e009579. PubMed ID: 30371203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation.
    Nguyen MC; Park JT; Jeon YG; Jeon BH; Hoe KL; Kim YM; Lim HK; Ryoo S
    Yonsei Med J; 2016 Nov; 57(6):1329-38. PubMed ID: 27593859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginase Inhibitor 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-Glucoside Activates Endothelial Nitric Oxide Synthase and Improves Vascular Function.
    Yi B; Nguyen MC; Won MH; Kim YM; Ryoo S
    Planta Med; 2017 Feb; 83(3-04):210-216. PubMed ID: 27392245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Arginase Inhibitor Derived from Scutellavia indica Restored Endothelial Function in ApoE-Null Mice Fed a High-Cholesterol Diet.
    Hwang HM; Lee JH; Min BS; Jeon BH; Hoe KL; Kim YM; Ryoo S
    J Pharmacol Exp Ther; 2015 Oct; 355(1):57-65. PubMed ID: 26265320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpressed p32 localized in the endoplasmic reticulum and mitochondria negatively regulates calcium‑dependent endothelial nitric oxide synthase activit.
    Choi K; Koo BH; Yoon BJ; Jung M; Yun HY; Jeon BH; Won MH; Kim YM; Mun JY; Lim HK; Ryoo S
    Mol Med Rep; 2020 Sep; 22(3):2395-2403. PubMed ID: 32705193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginase inhibition by piceatannol-3'-O-β-D-glucopyranoside improves endothelial dysfunction via activation of endothelial nitric oxide synthase in ApoE-null mice fed a high-cholesterol diet.
    Woo A; Shin W; Cuong TD; Min B; Lee JH; Jeon BH; Ryoo S
    Int J Mol Med; 2013 Apr; 31(4):803-10. PubMed ID: 23443634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginase II protein regulates Parkin-dependent p32 degradation that contributes to Ca2+-dependent eNOS activation in endothelial cells.
    Koo BH; Won MH; Kim YM; Ryoo S
    Cardiovasc Res; 2022 Mar; 118(5):1344-1358. PubMed ID: 33964139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial nitric oxide synthase activation through obacunone-dependent arginase inhibition restored impaired endothelial function in ApoE-null mice.
    Yoon J; Park M; Lee Jh; Min BS; Ryoo S
    Vascul Pharmacol; 2014 Mar; 60(3):102-9. PubMed ID: 24509132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piceatannol-3'-O-beta-D-glucopyranoside as an active component of rhubarb activates endothelial nitric oxide synthase through inhibition of arginase activity.
    Woo A; Min B; Ryoo S
    Exp Mol Med; 2010 Jul; 42(7):524-32. PubMed ID: 20543547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p38 mitogen-activated protein kinase is involved in arginase-II-mediated eNOS-uncoupling in obesity.
    Yu Y; Rajapakse AG; Montani JP; Yang Z; Ming XF
    Cardiovasc Diabetol; 2014 Jul; 13():113. PubMed ID: 25034973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS.
    Elms S; Chen F; Wang Y; Qian J; Askari B; Yu Y; Pandey D; Iddings J; Caldwell RB; Fulton DJ
    Am J Physiol Heart Circ Physiol; 2013 Sep; 305(5):H651-66. PubMed ID: 23792682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of eNOS and preserved endothelial function in endothelial-specific arginase 1-deficient mice.
    Heuser SK; LoBue A; Li J; Zhuge Z; Leo F; Suvorava T; Olsson A; Schneckmann R; Guimaraes Braga DD; Srivrastava T; Montero L; Schmitz OJ; Schmitt JP; Grandoch M; Weitzberg E; Lundberg JO; Pernow J; Kelm M; Carlström M; Cortese-Krott MM
    Nitric Oxide; 2022 Aug; 125-126():69-77. PubMed ID: 35752264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginase II activity regulates cytosolic Ca
    Koo BH; Hong D; Hong HD; Lim HK; Hoe KL; Won MH; Kim YM; Berkowitz DE; Ryoo S
    Exp Mol Med; 2019 Jun; 51(6):1-12. PubMed ID: 31155612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginase II inhibition prevents nitrate tolerance.
    Khong SM; Andrews KL; Huynh NN; Venardos K; Aprico A; Michell DL; Zarei M; Moe KT; Dusting GJ; Kaye DM; Chin-Dusting JP
    Br J Pharmacol; 2012 Aug; 166(7):2015-23. PubMed ID: 22288373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine attenuates methylglyoxal- and high glucose-induced endothelial dysfunction and oxidative stress by an endothelial nitric-oxide synthase-independent mechanism.
    Dhar I; Dhar A; Wu L; Desai K
    J Pharmacol Exp Ther; 2012 Jul; 342(1):196-204. PubMed ID: 22518022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of normal blood pressure is dependent on IP3R1-mediated regulation of eNOS.
    Yuan Q; Yang J; Santulli G; Reiken SR; Wronska A; Kim MM; Osborne BW; Lacampagne A; Yin Y; Marks AR
    Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8532-7. PubMed ID: 27402766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial arginase II constrains endothelial NOS-3 activity.
    Lim HK; Lim HK; Ryoo S; Benjo A; Shuleri K; Miriel V; Baraban E; Camara A; Soucy K; Nyhan D; Shoukas A; Berkowitz DE
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3317-24. PubMed ID: 17827260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syringaresinol causes vasorelaxation by elevating nitric oxide production through the phosphorylation and dimerization of endothelial nitric oxide synthase.
    Chung BH; Kim S; Kim JD; Lee JJ; Baek YY; Jeoung D; Lee H; Choe J; Ha KS; Won MH; Kwon YG; Kim YM
    Exp Mol Med; 2012 Mar; 44(3):191-201. PubMed ID: 22170035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.